Topic · page 27 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,041–1,080 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

Rheumatology (Oxford)28 Dec 2023
Effect of digital monitoring and counselling on self-management ability in patients with rheumatoid arthritis: a randomised controlled trial
Randomized controlled trial
Clin Exp Rheumatol28 Dec 2023
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience
Cohort study
RMD Open26 Dec 2023
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
Research article
Semin Arthritis Rheum23 Dec 2023
Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand – A retrospective cohort study
Cohort study
Clin Exp Rheumatol23 Dec 2023
The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysis
Meta-analysis
Rheumatology (Oxford)21 Dec 2023
Patient–physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation
Secondary analysis
RMD Open20 Dec 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
Cohort study
Arthritis Care Res (Hoboken)20 Dec 2023
Humoral and T Cell Response to SARS‐CoV‐2 Vaccination in Patients With Rheumatoid Arthritis
Cohort study
RMD Open19 Dec 2023
Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis
Cohort study
Clin Exp Rheumatol19 Dec 2023
Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry
Cohort study
Arthritis Care Res (Hoboken)18 Dec 2023
Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study
Cohort study
Arthritis Care Res (Hoboken)16 Dec 2023
Capturing Patient Value in an Economic Evaluation
Cohort study
Arthritis Res Ther15 Dec 2023
Comprehensive multi-omics analysis reveals the core role of glycerophospholipid metabolism in rheumatoid arthritis development
Mechanistic study
Clin Exp Rheumatol14 Dec 2023
Exploring the link between dietary omega-3 and omega-6 fatty acid intake and rheumatoid arthritis risk: NHANES 1999-2020 study
Cross-sectional study
Semin Arthritis Rheum13 Dec 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set
Guideline or statement
Rheumatology (Oxford)13 Dec 2023
A potential role for chlamydial infection in rheumatoid arthritis development
Case-control study
Scand J Rheumatol12 Dec 2023
Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study
Cohort study
Semin Arthritis Rheum10 Dec 2023
Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials
Meta-analysis
Arthritis Care Res (Hoboken)10 Dec 2023
Decline in Incidence of Extra‐Articular Manifestations of Rheumatoid Arthritis: A Population‐Based Cohort Study
Cohort study
Semin Arthritis Rheum9 Dec 2023
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
Cohort study
Semin Arthritis Rheum8 Dec 2023
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
Cohort study
RMD Open6 Dec 2023
Time trends in the burden of autoimmune diseases across the BRICS: an age–period–cohort analysis for the GBD 2019
Cohort study
Arthritis Care Res (Hoboken)6 Dec 2023
Decision‐Making Around COVID‐19 Public Health Measures and Implications for Self‐Care Activities: Experiences of Persons With Rheumatoid Arthritis
Research article
Clin Exp Rheumatol5 Dec 2023
Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data
Cohort study
Rheumatology (Oxford)4 Dec 2023
Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers
Cross-sectional study
Rheumatology (Oxford)4 Dec 2023
Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
Cross-sectional study
J Rheumatol1 Dec 2023
Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody–Positive At-Risk Individuals Without Arthritis
Cohort study
RMD Open1 Dec 2023
Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database
Cohort study
RMD Open1 Dec 2023
Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association
Cohort study
J Rheumatol1 Dec 2023
A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease
Mechanistic study
Arthritis Res Ther1 Dec 2023
Machine learning and molecular subtype analyses provide insights into PANoptosis-associated genes in rheumatoid arthritis
Guideline or statement
Semin Arthritis Rheum30 Nov 2023
A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis
Meta-analysis
Joint Bone Spine30 Nov 2023
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
Meta-analysis
RMD Open30 Nov 2023
Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank
Cohort study
Arthritis Res Ther30 Nov 2023
The relation between synovitis of individual finger joints and grip force over the first 5 years in early rheumatoid arthritis — a cohort study
Cohort study
Arthritis Rheumatol28 Nov 2023
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoid Arthritis
Mechanistic study
Semin Arthritis Rheum24 Nov 2023
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease
Cohort study
Semin Arthritis Rheum24 Nov 2023
Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study
Cohort study
Arthritis Res Ther24 Nov 2023
Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis
Cohort study
Clin Exp Rheumatol24 Nov 2023
Dose reduction of rituximab in clinical practice: a retrospective cohort study of rheumatoid arthritis patients in low disease activity on rituximab
Cohort study

All 1,564 Briefs in ExploreShowing Briefs 1,041–1,080 of 1,564, newest first